- Genzyme - Wikipedia
Genzyme (also known as Genzyme Transgenics Corp or GTC Biotherapeutics) was an American biotechnology company based in Cambridge, Massachusetts From its acquisition in 2011 to 2022 Genzyme operated as a fully owned subsidiary of Sanofi
- Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USA
Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments
- Eleven years after buying Genzyme, Sanofi officially ditches . . . - STAT
Eleven years after Sanofi bought Genzyme for about $20 1 billion, the parent company said Thursday it will no longer call its specialty care unit Sanofi Genzyme ― just Sanofi, as part of a
- What is Sanofi Genzyme?: The Story of a Rare Disease Pioneer
Discover **what is Sanofi Genzyme**, the former biotech powerhouse acquired by Sanofi Explore its history, focus on rare diseases, key products, and how its legacy reshaped Sanofi's specialty care division
- Genzyme Corporation -- Company History
Genzyme Corporation is a leading biotechnology company that focuses on five business areas: therapeutics, diagnostic services, diagnostic products, pharmaceutical and fine chemicals, and tissue repair
- Genzymes Growth Story - Guidechem Chemical Network
Genzyme's growth story showcases a biotech company that thrived through diversification and innovative financing strategies Despite challenges, including its reliance on rare disease treatments and later bottlenecks, it became a major player before being acquired by Sanofi
- Genzyme | Company Overview News - Forbes
Genzyme Corporation (Genzyme) is a biotechnology company The Company's product and service portfolio is focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer,
- Genzyme: Pioneering Rare Disease Treatments - Biology Insights
Genzyme was founded in 1981, aiming to apply advanced biotechnology to develop treatments for diseases Its founders recognized a need for innovative approaches to conditions that lacked effective therapies, particularly rare ones
|